FTC seeks to block Amgen's $27.8 billion drug deal
(The Center Square) -- The Federal Trade Commission said Tuesday it wants to block Amgen's $27.8 billion bid to acquire Horizon Therapeutics.
(The Center Square) -- The Federal Trade Commission said Tuesday it wants to block Amgen's $27.8 billion bid to acquire Horizon Therapeutics.